Government investigators determined that top-level FDA officials were told months in advance of a public announcement that the agency would reject the controversial Plan B "morning after" pill. That decision also came before the FDA had completed its scientific review of the drug and was made with the active--and unusual--involvement of then FDA Commissioner Mark McClellan. Investigators for the nonpartisan General Accounting Office said that they found a variety of irregularities linked to Plan B. Critics immediately heralded the results of the probe as proof that politics had trumped science in the drug-approval process. The FDA, though, rejected the conclusions, saying that investigators appeared to have failed to consider the agency's input before reaching its conclusions.
- see this article from The Washington Post